
Noble E. Jarrell
Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1622, 1624, 1609 |
| Total Applications | 1419 |
| Issued Applications | 950 |
| Pending Applications | 180 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15711027
[patent_doc_number] => 20200102279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => NEW PROCESS FOR THE SYNTHESIS OF FIROCOXIB
[patent_app_type] => utility
[patent_app_number] => 16/605154
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605154
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605154 | Process for the synthesis of firocoxib | Apr 13, 2017 | Issued |
Array
(
[id] => 11987756
[patent_doc_number] => 20170291911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'Ataxia Telengiectasia And RAD3-Related (ATR) Inhibitors And Methods Of Their Use'
[patent_app_type] => utility
[patent_app_number] => 15/486017
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26162
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486017
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/486017 | Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use | Apr 11, 2017 | Issued |
Array
(
[id] => 16969305
[patent_doc_number] => 11065251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => PAK1 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/095709
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 8596
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095709 | PAK1 inhibitors and uses thereof | Apr 2, 2017 | Issued |
Array
(
[id] => 16512892
[patent_doc_number] => 20200392150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/090568
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090568
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090568 | Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof | Mar 27, 2017 | Abandoned |
Array
(
[id] => 17178320
[patent_doc_number] => 11155554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Rigid chiral redox-active isosceles triangular materials
[patent_app_type] => utility
[patent_app_number] => 16/085436
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 38
[patent_no_of_words] => 11659
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085436 | Rigid chiral redox-active isosceles triangular materials | Mar 15, 2017 | Issued |
Array
(
[id] => 13890669
[patent_doc_number] => 10197881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Complimentary polymer electrochromic device
[patent_app_type] => utility
[patent_app_number] => 15/455984
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 15
[patent_no_of_words] => 16431
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455984 | Complimentary polymer electrochromic device | Mar 9, 2017 | Issued |
Array
(
[id] => 11704669
[patent_doc_number] => 20170173168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'ACETYLENEDICARBOXYL LINKERS AND THEIR USES IN SPECIFIC CONJUGATION OF A CELL-BINDING MOLECULE'
[patent_app_type] => utility
[patent_app_number] => 15/448639
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26671
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448639 | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule | Mar 2, 2017 | Issued |
Array
(
[id] => 14324125
[patent_doc_number] => 10293055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
[patent_app_type] => utility
[patent_app_number] => 15/448634
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22576
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 405
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448634
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448634 | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule | Mar 2, 2017 | Issued |
Array
(
[id] => 16460732
[patent_doc_number] => 10844066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides
[patent_app_type] => utility
[patent_app_number] => 16/082712
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15057
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082712 | 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides | Feb 28, 2017 | Issued |
Array
(
[id] => 11662633
[patent_doc_number] => 20170151340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'Conjugates Containing Hydrophilic Spacer Linkers'
[patent_app_type] => utility
[patent_app_number] => 15/431157
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38372
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431157
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431157 | Conjugates containing hydrophilic spacer linkers | Feb 12, 2017 | Issued |
Array
(
[id] => 14482793
[patent_doc_number] => 10328157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
[patent_app_type] => utility
[patent_app_number] => 15/423695
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22546
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1836
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/423695 | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule | Feb 2, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 16791638
[patent_doc_number] => 20210121455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => OPIOID RECEPTOR ANTAGONIST CONJUGATE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/074268
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074268 | Opioid receptor antagonist conjugate and use thereof | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 14761953
[patent_doc_number] => 10392361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Process for the synthesis of intermediates of Nebivolol
[patent_app_type] => utility
[patent_app_number] => 16/071741
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4062
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071741 | Process for the synthesis of intermediates of Nebivolol | Jan 22, 2017 | Issued |
Array
(
[id] => 13826507
[patent_doc_number] => 20190016738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => SUPRAMOLECULAR ASSEMBLY OF RIGID MACROCYCLES THROUGH COOPERATIVE HYDROGEN BOND INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 16/069940
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069940 | Supramolecular assembly of rigid macrocycles through cooperative hydrogen bond interactions | Jan 12, 2017 | Issued |
Array
(
[id] => 16460728
[patent_doc_number] => 10844062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/074950
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 24145
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074950 | Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof | Jan 10, 2017 | Issued |
Array
(
[id] => 11604042
[patent_doc_number] => 20170121344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/401767
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52920
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15401767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/401767 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | Jan 8, 2017 | Abandoned |